3 results
Approved WMOWill not start
The primary objective of this study is to assess the hemostatic efficacy and safety of rVWF with or without ADVATE in subjects (* 18 years) diagnosed with hereditary severe VWD undergoing major and minor elective surgical procedures.
Approved WMOPending
The objective of this study is to evaluate the clinical efficacy, biological effects and safety of anifrolumab treatment in pSS.
Approved WMOCompleted
To evaluate the effect of crizanlizumab + standard of care compared to standard of care alone on albuminuria (ACR) decrease at 12 months